Preview

The Russian Archives of Internal Medicine

Advanced search

Myocarditis Associated with COVID-19: Review of a Fatal Case Report

https://doi.org/10.20514/2226-6704-2024-14-3-221-227

EDN: RGCHKK

Abstract

   To date more than 774 million people worldwide were infected with the SARS-CoV-2 virus (data for February 2024), and approximately 7 million people have already died from COVID-19. Since the beginning of the COVID-19 pandemic, there have been many reports and studies on damage involvement of the SARS-CoV-2 virus not only the respiratory but cardiovascular system as well, including myocardial damage, endothelial dysfunction, acute coronary syndromes, arrhythmias, myocarditis, thromboembolism, heart failure, hypotension, cardiogenic shock and even cardiac arrest. In addition, symptomatic COVID-19 infection with a severe course is more common in comorbid patients with a history of hypertension, diabetes, obesity, cancer or chronic obstructive pulmonary disease. According to the latest literature data, the occurrence of myocarditis associated with a new coronavirus infection is more often observed in young males and is associated with a severe or even fatal prognosis, which determines the relevance of a detailed study of the pathogenetic mechanisms and therapeutic possibilities for myocardial damage prophylaxis, relieving the main disease symptoms and unfavorable prognosis prevention. To date, there are also studies indicating that acute myocarditis could be a complication not only of the infection itself, but even one of the severe post-vaccination against SARS-CoV-2complications.

   The purpose of this study is to research the lethal clinical case of acute infectious myocarditis complicated the course of a new coronavirus infection.

   A retrospective analysis of the patient’s medical history with the final diagnosis: acute coronaviral myocarditis against the background of non-compact left ventricle myocardium was carried out.

About the Authors

O. V. Soldatova
Order of the Red Banner of Labor Medical Institute named after. S. I. Georgievsky, Crimean Federal University named after V. I. Vernadsky”
Russian Federation

Olga V. Soldatova

Department of Internal Medicine № 1

Simferopol



I. Y. Goryanskaya
Order of the Red Banner of Labor Medical Institute named after. S. I. Georgievsky, Crimean Federal University named after V. I. Vernadsky”
Russian Federation

Department of Internal Medicine № 1

Simferopol



L. E. Namazova
Order of the Red Banner of Labor Medical Institute named after. S. I. Georgievsky, Crimean Federal University named after V. I. Vernadsky”
Russian Federation

Department of Internal Medicine № 1

Simferopol



O. Y. Muhtarov
Order of the Red Banner of Labor Medical Institute named after. S. I. Georgievsky, Crimean Federal University named after V. I. Vernadsky”
Russian Federation

Department of Internal Medicine № 1

Simferopol



References

1. Shu H., Zhao Ch., Wang D. Understanding COVID-19-related myocarditis: pathophysiology, diagnosis, and treatment strategies. Cardiol Plus. 2023; 8(2): 72–81. doi: 10.1097/CP9.0000000000000046

2. Torre-Amione G., Kapadia S., Lee J. et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996; 93: 704-11. doi: 10.1161/01.cir.93.4.704

3. Oudit G. Y., Kassiri Z., Jiang C. et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39: 618-25. doi: 10.1111/j.1365-2362.2009.02153.x

4. Inciardi R. M., Lupi L., Zaccone G. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Jul 1; 5(7):819-824. doi: 10.1001/jamacardio.2020.1096

5. Tang N., Li D., Wang X. et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 8447. doi: 10.1111/jth.14768

6. Driggin E., Madhavan M. V., Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020; 75(18): 2352–2371. doi: 10.1016/J.JACC.2020.03.031

7. Castiello T., Georgiopoulos G., Finocchiaro G. et al. COVID-19 and myocarditis : a systematic review and overview of current challenges. Heart Failure Reviews. 2022; 27(1): 251-261. doi: 10.1007/s10741-021-10087-9.

8. Gessler N., Gunawardene M. A., Wohlmuth P. et al. Clinical outcome, risk assessment, and seasonal variation in hospitalized COVID-19 patients-Results from the CORONA Germany study. PLoS One. 2021. 17; 16(6): e0252867. doi: 10.1371/journal.pone.0252867

9. Aghagoli G., Gallo Marin B., Soliman L. B., Sellke F. W. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications : A review. J. Card. Surg. 2020. 35(6): 1302–1305. doi: 10.1111/jocs.14538.

10. Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46(5): 846-848. doi: 10.1007/s00134-020-05991-x

11. Pirzada A., Mokhtar A. T., Moeller A. D. COVID-19 and Myocarditis: What Do We Know So Far? CJC Open.2020; 2(4): 278–285. doi: 10.1016/J.CJCO.2020.05.005.

12. Gao, L., Jiang, D., Wen X. et al. Prognostic value of NT-proBNP in patients with severe COVID-19. Gao et al. Respiratory Research. 2020; 21: 83. doi: 10.1186/s12931-020-01352-w

13. Akhmerov A., Marban E. COVID-19 and the Heart. Circulation. 2020.8; 126(10): 1443-1455. doi: 10.1161/CIRCRESAHA.120.317055

14. Aras D., Tufekcioglu O., Ergun K. et al. Clinical features of isolated ventricular noncompaction in adults long-term clinical course, echocardiographic properties, and predictors of left ventricular failure. J. Card. Fail. 2006; 12(9): 726-733. doi: 10.1016/j.cardfail.2006.08.002

15. Engberding R., Yelbuz T. M., Breithardt G. Isolated noncompaction of the left ventricular myocardium — a review of the literature two decades after the initial case description. Clin Res Cardiol. 2007; 96(7): 481– 488. doi: 10.1007/s00392-007-0528-6.

16. Long B., Brady W. J., Koyfman A. et al. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020; 38(7): 1504-1507. doi: 10.1016/j.ajem.2020.04.048

17. Practice of echocardiography during the COVID-19 pandemic: guidance from the Canadian Society of Echocardiography [Electronic resource]. URL: http://csecho.ca/wp-content/uploads/2020/03/CSE-COVID-19-Guidance_English-1.pdf (access date: 15. 10. 2021).


Review

For citations:


Soldatova O.V., Goryanskaya I.Y., Namazova L.E., Muhtarov O.Y. Myocarditis Associated with COVID-19: Review of a Fatal Case Report. The Russian Archives of Internal Medicine. 2024;14(3):221-227. https://doi.org/10.20514/2226-6704-2024-14-3-221-227. EDN: RGCHKK

Views: 350


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2226-6704 (Print)
ISSN 2411-6564 (Online)